| Results summary | View all lists in L2L MDB | View all genes in P01B.profile.ud50 |
|
Down-regulated at any timepoint following treatment of WS1 human skin fibroblasts with UVC at a high dose (50 J/m^2) (clusters d1-d9) enrichment: 2.55-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 201668_X_AT | MARCKS | myristoylated alanine-rich protein kinase C substrate | |||||||||||
| 200769_S_AT | MAT2A | methionine adenosyltransferase II, alpha | |||||||||||
| 202887_S_AT | DDIT4 | DNA-damage-inducible transcript 4 | |||||||||||
| 203692_S_AT | E2F3 | R | E2F transcription factor 3 | ||||||||||
| 217168_S_AT | HERPUD1 | X | P | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 | |||||||||
| 205042_AT | GNE | E | C | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | |||||||||
| 203752_S_AT | JUND | R | jun D proto-oncogene | ||||||||||
| 200959_AT | FUS | fusion (involved in t(12;16) in malignant liposarcoma) | |||||||||||